Battling Antimicrobial Resistance in Northwest Syria: A Call for Urgent Action

By Melike Belenli Gümüş

November 26, 2024

Antimicrobial resistance (AMR) poses a significant threat to global health. A recent article from the World Health Organization’s Eastern Mediterranean Regional Office (EMRO) enlighten the critical issue of antimicrobial resistance (AMR) and the important role of healthcare workers in northwest Syria. It highlights the urgent call from Syrian health professionals for action ahead of World Antimicrobial Awareness Week. Understanding the intricacies of antibiotic usage, the advantages and disadvantages, as well as the burden of AMR, is essential in this challenging context.

Balancing the Benefits and Risks of Antibiotic Use in Conflict Zones

Antibiotics are vital for treating bacterial infections and they are crucial in emergency care, especially in conflict-affected areas like northwest Syria. However, their misuse and overuse, such as purchasing without prescriptions or not completing treatment courses, accelerate AMR. The lack of diagnostic tools in these regions often leads healthcare workers to rely on broad-spectrum antibiotics, further increasing the risk of AMR.

Understanding Antimicrobial Resistance

Antimicrobial resistance occurs when bacteria evolve to resist the effects of antibiotics. This resistance complicates treatments and endangers lives. Dr Mohammad Wahid Rajab Bek, Head of the Syrian Association of Infectious Diseases, highlights the misuse of antibiotics as a leading cause. “Antibiotics are lifesaving when used properly, but misuse has become widespread,” he warns. Many people self-prescribe antibiotics for common colds and fevers, exacerbating the problem.

The Economic and Health Impacts

The financial burden of AMR is substantial. Dr Bek notes a troubling rise in antibiotic-resistant urinary tract infections. “Infections once easily treatable now require stronger, more expensive drugs,” he explains. Treatment costs can soar from US$ 15–US$ 20 to US$ 500–US$ 1000, overwhelming health systems and patients alike. Beyond financial strain, resistant infections lead to prolonged illnesses and weakened immune systems. “Even minor infections can escalate into severe complications or death if unresponsive to antibiotics,” Dr Bek warns.

Strategies to Combat AMR

To address AMR, hospitals have implemented strict antibiotic controls. “Awareness is key,” stresses Dr Bek. Antibiotics are dispensed through a controlled system with specialist consultation. Preventive measures, such as administering specific antibiotics before surgeries, are also emphasised. Patients play a crucial role in this battle. Completing the prescribed course is essential, even if symptoms improve.

A Global Call to Action

World AMR Awareness Week (WAAW) is a global campaign to raise awareness about AMR and promote responsible antimicrobial use. This year, the World Health Organization (WHO), in partnership with the Food and Agriculture Organization (FAO), the UN Environment Programme (UNEP), and the World Organization for Animal Health (WOAH), has developed a campaign guide. This collaboration highlights the need for a united front against AMR and encourages all sectors to participate.

Antimicrobial resistance is a pressing global health issue that demands immediate attention. By educating ourselves and advocating for responsible antibiotic use, we can act now to safeguard future generations. Let us work together to combat antimicrobial resistance and ensure a healthier world for all.

Reference url

Recent Posts

HIV prevention injection
   

FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Prevention

🌍 Will Yeztugo Approval and Access Strategy Deliver an Inflection Point in HIV/AIDS?

Yeztugo (lenacapavir), a twice-yearly injection, redefines long-acting HIV prevention with 96–100% efficacy. Gilead’s access strategy—insurance, assistance, and generics for 120 countries—targets global impact. Can it balance $28,218 U.S. costs with equity for 1.3M annual infections? My article explores health economics, public health, and market dynamics.

📖 Read how Yeztugo’s access strategy could transform long-acting HIV prevention

#SyenzaNews #GlobalHealth #HIVPrevention #Yeztugo #PrEP

essential prescription drugs
       

Canada Launches Consultation for Essential Prescription Drugs List

💊 Are you curious about how Canada plans to make essential prescription drugs accessible for everyone?

Canada’s Drug Agency has launched a national consultation to create a list of essential prescriptions that aim to ensure equitable access, improve health outcomes, and reduce costs. This initiative marks a key step towards universal pharmacare and highlights the importance of evidence-based practices in healthcare.

Dive into our latest article to learn more about the implications for patients, policymakers, and the broader healthcare system!

#SyenzaNews #healthcare #HealthEconomics

ACIP vaccine policy concerns
     

ACIP Vaccine Policy Concerns

🛑 Is the future of vaccine policy at risk?

The recent overhaul of the US Advisory Committee on Immunization Practices (ACIP) raises critical concerns about the integrity and transparency in vaccine recommendations. The abrupt removal of longstanding members may disrupt the essential processes that have historically upheld public trust and immunization success.

Curious about the implications for health policy and public health? Dive into the full analysis to understand the balance needed between continuity and reform!

#SyenzaNews #HealthcarePolicy #HealthEconomics #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.